Literature DB >> 12429542

Loss of transforming growth factor counteraction on interleukin 1 mediated effects in cartilage of old mice.

A Scharstuhl1, H M van Beuningen, E L Vitters, P M van der Kraan, W B van den Berg.   

Abstract

OBJECTIVE: To investigate if a difference exists between young and old mice in the response of articular cartilage to interleukin 1 (IL1) and transforming growth factor beta (TGFbeta) alone or in combination.
METHODS: The interaction of IL1 and TGFbeta was studied in cartilage of young (three months) and old mice (18 months) both in vivo and in vitro. Therefore, IL1, TGFbeta, or IL1 together with TGFbeta was injected into the knee joints of mice on days 1, 3, and 5 before harvest of the patellae on day 6. Alternatively, isolated patellae were stimulated with IL1, TGFbeta, or IL1 together with TGFbeta in culture for 48 hours. Proteoglycan (PG) synthesis and nitric oxide (NO) production were measured.
RESULTS: IL1 inhibited PG synthesis and increased NO production in cartilage of both young and old mice. On the other hand, TGFbeta stimulated PG synthesis and reduced NO production in both age groups. Importantly, TGFbeta was able to counteract IL1 mediated effects on PG synthesis and NO production in young but not in old mice.
CONCLUSIONS: Contrary to the findings in young mice, the cartilage of old animals does not antagonise IL1 effects via TGFbeta. This loss of responsiveness to the pivotal cytokine TGFbeta on effects of IL1 can be important in the initiation and progression of osteoarthritis (OA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429542      PMCID: PMC1753968          DOI: 10.1136/ard.61.12.1095

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

1.  Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.

Authors:  H J Zhu; J Iaria; A M Sizeland
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 2.  The role of the chondrocyte in osteoarthritis.

Authors:  M B Goldring
Journal:  Arthritis Rheum       Date:  2000-09

Review 3.  The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models.

Authors:  M B Goldring
Journal:  Connect Tissue Res       Date:  1999       Impact factor: 3.417

4.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.

Authors:  L C Tetlow; D J Adlam; D E Woolley
Journal:  Arthritis Rheum       Date:  2001-03

5.  The regulation of MMPs and TIMPs in cartilage turnover.

Authors:  T Cawston; C Billington; C Cleaver; S Elliott; W Hui; P Koshy; B Shingleton; A Rowan
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

6.  Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage of the mouse patella: in vitro and in vivo studies with 35S-sulfate, 3H-glucosamine, and 3H-acetate.

Authors:  B J de Vries; W B van den Berg; E Vitters; L B van de Putte
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation.

Authors:  S Chandrasekhar; A K Harvey
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

8.  TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage.

Authors:  X Yang; L Chen; X Xu; C Li; C Huang; C X Deng
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

9.  Active and latent forms of transforming growth factor beta activity in synovial effusions.

Authors:  R Fava; N Olsen; J Keski-Oja; H Moses; T Pincus
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

Review 10.  Anti-cytokine therapy in chronic destructive arthritis.

Authors:  W B van den Berg
Journal:  Arthritis Res       Date:  2000-11-10
View more
  18 in total

Review 1.  The changing role of TGFβ in healthy, ageing and osteoarthritic joints.

Authors:  Peter M van der Kraan
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

Review 2.  Events in articular chondrocytes with aging.

Authors:  Daniel J Leong; Hui B Sun
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

3.  Scaffoldless tissue-engineered cartilage for studying transforming growth factor beta-mediated cartilage formation.

Authors:  Robert D Chavez; Rosa Serra
Journal:  Biotechnol Prog       Date:  2019-09-11

Review 4.  Effects of aging on articular cartilage homeostasis.

Authors:  Martin Lotz; Richard F Loeser
Journal:  Bone       Date:  2012-03-28       Impact factor: 4.398

5.  An in vitro tissue model to study the effect of age on nucleus pulposus cells.

Authors:  R A Kandel; D Hamilton; C Séguin; S-Q Li; C Arana; R Pilliar
Journal:  Eur Spine J       Date:  2007-08-18       Impact factor: 3.134

Review 6.  A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis.

Authors:  Peter M van der Kraan; Esmeralda N Blaney Davidson; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2010-01-29       Impact factor: 5.156

7.  IL-1beta inhibits TGFbeta in the temporomandibular joint.

Authors:  W H Lim; J Toothman; J H Miller; R H Tallents; S M Brouxhon; M E Olschowka; S Kyrkanides
Journal:  J Dent Res       Date:  2009-06       Impact factor: 6.116

8.  Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.

Authors:  J A Roman-Blas; D G Stokes; S A Jimenez
Journal:  Osteoarthritis Cartilage       Date:  2007-06-29       Impact factor: 6.576

Review 9.  Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix.

Authors:  R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2009-03-12       Impact factor: 6.576

Review 10.  Age-dependent alteration of TGF-β signalling in osteoarthritis.

Authors:  Peter M van der Kraan; Marie-José Goumans; Esmeralda Blaney Davidson; Peter ten Dijke
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.